Legislation


SB 900 (see companion bill HB 5690) – Michigan

Status: Inactive / Dead
Year Introduced: 2018
Link: http://www.legislature.mi.gov/(S(qszmo4jwq1bd3sgwolgugunv))/mileg.aspx?page=getobject&objectname=2018-SB-0900&query=on

PROHIBIT MANUFACTURERS FROM CHARGING EXCESSIVE PRICES OR UNCONSCIONABLE INCREASES IN WHOLESALE ACQUISITION COSTS: A manufacturer of prescription drugs that is engaged in the conduct of trade or commerce shall not charge an excessive price for a prescription drug or change the price for a prescription drug in a manner that results in an unconscionable increase in the wholesale acquisition cost of that drug. If the drug consumer protection commission alleges that a manufacturer is charging an excessive price for a prescription drug or that there has been an unconscionable increase in a manufacturer’s wholesale acquisition cost for a prescription drug, the Attorney General must investigate.  The Attorney General can bring a class action suit for violations.


Return to Database Search

© 2018-2019 The SLIHCQ DatabaseInitial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.

Associated Litigation:

No items found

Leave A Comment